Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Applying to ClinRé 001-022 (Premier Cancer Care and Infusion Center) · Fresno, California
Answer a few short questions to share with the research team.